Quotient Sciences is a specialized, limited company focused on accelerating the drug development and manufacturing process for pharmaceutical clients. Established in 2004, Quotient Sciences operates as an accelerator, providing comprehensive support throughout the lifecycle of a drug candidate. The company’s core services encompass candidate selection, initial process development, and ultimately, successful commercial launch. Quotient Sciences specializes in providing expertise in pharmaceutical CRDMO services, including the design and execution of Phase 1 clinical trials, robust drug manufacturing, and meticulous quality control. The company’s strategic focus is on identifying promising drug candidates and providing the necessary infrastructure to transition them to market. Quotient Sciences operates within a range of industries, including biotechnology, pharmaceutical, and clinical research. The company’s small size and dedicated team position it as a nimble and responsive partner for clients seeking specialized support. Quotient Sciences is currently employing a skilled workforce and maintains an international presence, though currently lacks a global operational footprint. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology, - 7320: Pharmaceutical Clinical Trials, - 7311: Pharmaceutical Manufacturing.

Quotient Sciences is a specialized, limited company focused on accelerating the drug development and manufacturing process for pharmaceutical clients. Established in 2004, Quotient Sciences operates as an accelerator, providing comprehensive support throughout the lifecycle of a drug candidate. The company’s core services encompass candidate selection, initial process development, and ultimately, successful commercial launch. Quotient Sciences specializes in providing expertise in pharmaceutical CRDMO services, including the design and execution of Phase 1 clinical trials, robust drug manufacturing, and meticulous quality control. The company’s strategic focus is on identifying promising drug candidates and providing the necessary infrastructure to transition them to market. Quotient Sciences operates within a range of industries, including biotechnology, pharmaceutical, and clinical research. The company’s small size and dedicated team position it as a nimble and responsive partner for clients seeking specialized support. Quotient Sciences is currently employing a skilled workforce and maintains an international presence, though currently lacks a global operational footprint. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology, - 7320: Pharmaceutical Clinical Trials, - 7311: Pharmaceutical Manufacturing.